This study evaluates the date of the first appropriate and/or inappropriate therapy in
      patients implanted with a Guidant PRIZM or VITALITY defibrillator and is evaluating eventual
      predictive risk factors for appropriate/inappropriate therapies as well as the influence of
      the programmed parameters on these therapies.

OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator

Ventricular Tachycardia

Ventricular Fibrillation

The registry measured the times to, and studied the determinants of, first appropriate (FAT)
      and inappropriate (FIT) therapy delivered by single, dual and triple chamber (CRT-D) ICD
      implanted for primary and secondary prevention indications.

Prizm, Vitality, Renewal

CHG Aix en Provence

CHG Albi

CH Amiens

CHU Angers

Hopital Angouleme

CH Avignon

CH Besancon

CHU Hopital la Cavale Blanche

Hopital Cote de Nacre

CHG Chateauroux

Hopital Antoine Beclere

CHU Clermont Ferrand

CHU Michalon

CH La Roche sur Yon

CHU Dupuytren

Hopital Neuro-cardiologique

CH St. Joseph

GH La Timone

Hopital Nord

CHG Martigues

Hôpital Princesse de Grâce

CHU Montpellier

CHU Nantes

CHU Nice

CHU D'Orleans

CHG Pau

CHRU Robert Debré

CHU Pontchaillou

CHU Rouen

CMC Arnaud Tzanck

CHU Toulon

CHU Rangueil

CHU Tours

OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator

About this trial

Study ID

Status

Type

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?